{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:38:57Z","timestamp":1790959137210,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ijpharm.2017.05.045","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T01:46:38Z","timestamp":1495503998000},"page":"79-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Dendrimer-conjugated peptide vaccine enhances clearance of Chlamydia trachomatis genital infection"],"prefix":"10.1016","volume":"527","author":[{"given":"Ingrid S.","family":"Ganda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirabela","family":"Hali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo L.C.","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine F.","family":"Padilha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro R.P.","family":"da Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Whittum-Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2017.05.045_bib0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/eye.1998.104","article-title":"Immunopathogenesis of conjunctival scarring in trachoma","volume":"12","author":"Abu El-Asrar","year":"1998","journal-title":"Eye"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size, shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0015","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/mp9002464","article-title":"Dendrimer internalization and intracellular trafficking in living cells","volume":"7","author":"Albertazzi","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1399-3011.1987.tb03319.x","article-title":"Reactions of N-hydroxysulfosuccinimide active esters","volume":"30","author":"Anjaneyulu","year":"1987","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s004300050071","article-title":"Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain","volume":"187","author":"Balin","year":"1998","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0030","doi-asserted-by":"crossref","DOI":"10.1097\/01.prs.0000222562.60260.f9","article-title":"Wound healing: an overview","volume":"117","author":"Broughton","year":"2006","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0035","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/art.27394","article-title":"Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial","volume":"62","author":"Carter","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0040","unstructured":"Centers for Disease Control and Prevention, Sexually Transmitted Disease Surveillance 2014, Atlanta, GA, USA: U.S. Department of Health and Human Services, 2015, (Available from URL: http:\/\/www.cdc.gov\/std\/stats1412\/chlamydia.htm)."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0045","doi-asserted-by":"crossref","first-page":"e5409","DOI":"10.1371\/journal.pone.0005409","article-title":"A vault nanoparticle vaccine induces protective mucosal immunity","volume":"4","author":"Champion","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0050","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1021\/bm9000298","article-title":"Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers","volume":"10","author":"Chauhan","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0055","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.ejmech.2007.12.021","article-title":"The effect of dendrimers on the pharmacodynamic and pharmacokinetic behaviors of non-covalently or covalently attached drugs","volume":"43","author":"Cheng","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0060","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.1158\/0008-5472.CAN-11-1766","article-title":"Peptide-conjugated PAMAM dendrimer as a universal DNA vaccine platform to target antigen-presenting cells","volume":"71","author":"Daftarian","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0065","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1128\/IAI.00357-13","article-title":"Animal models for studying female genital tract infection with Chlamydia trachomatis","volume":"81","author":"De Clercq","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2741\/1184","article-title":"Wound healing: an overview of acute, fibrotic and delayed healing","volume":"9","author":"Diegelmann","year":"2004","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0075","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.nano.2014.02.009","article-title":"Poly (lactic acid)\u2013poly (ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice","volume":"10","author":"Dixit","year":"2014","journal-title":"Nanomed: Naotechnol. Biol. Med."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0080","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1021\/mp200463e","article-title":"Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro","volume":"9","author":"Dobrovolskaia","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1381612823666170309151958","article-title":"Dendrimers effects on the immune system: insights into toxicity and therapeutic utility","volume":"23","author":"Dobrovolskaia","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1359-6446(01)01757-3","article-title":"Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications","volume":"6","author":"Esfand","year":"2001","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2011.06.015","article-title":"Biodegradable star HPMA polymer-drug conjugates: biodegradability, distribution and anti-tumor efficacy","volume":"154","author":"Etrych","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0100","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1021\/bc1005653","article-title":"Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticles","volume":"22","author":"Gaertner","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0105","first-page":"734","article-title":"Synovial Chlamydia trachomatis in patients with reactive arthritis\/Reiter's syndrome are viable but show aberrant gene expression","volume":"25","author":"Gerard","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1359-6446(04)03276-3","article-title":"Dendrimers and dendritic polymers in drug delivery","volume":"10","author":"Gillies","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(90)90267-D","article-title":"Zero-length crosslinking procedure with the use of active esters","volume":"185","author":"Grabarek","year":"1990","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fcimb.2013.00013","article-title":"Vaccine delivery using nanoparticles","volume":"3","author":"Gregory","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/mi.2007.19","article-title":"Chlamydia trachomatis infection: host immune responses and potential vaccines","volume":"1","author":"Hafner","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jama.1991.03470020051031","article-title":"Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma","volume":"266","author":"Hahn","year":"1991","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0135","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.drudis.2013.09.001","article-title":"Phage display as a technology delivering on the promise of peptide drug discovery","volume":"18","author":"Hamzeh-Mivehroud","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/bc900290d","article-title":"Dendrimers for vaccine and immunostimulatory uses. A review","volume":"21","author":"Heegaard","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0145","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2017.01.057","article-title":"Cellular internalization and transport of biodegradable polyester dendrimers on a model of the pulmonary epithelium and their formulation in pressurized metered-dose inhalers","volume":"520","author":"Heyder","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0150","doi-asserted-by":"crossref","first-page":"11109","DOI":"10.1021\/acs.chemrev.5b00109","article-title":"Synthetic nanoparticles for vaccines and immunotherapy","volume":"115","author":"Irvine","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fimmu.2014.00107","article-title":"Function and potentials of M. tuberculosis epitopes","volume":"5","author":"Ivanyi","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0160","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2010.04.027","article-title":"Dendrimer toxicity: let's meet the challenge","volume":"394","author":"Jain","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/vaccines5010003","article-title":"A protective vaccine against chlamydia genital infection using vault nanoparticles without an added adjuvant","volume":"5","author":"Jiang","year":"2017","journal-title":"Vaccines"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0170","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10719-010-9295-0","article-title":"Preparation, characterization and immunogenicity of HIV-1 related high-mannose oligosaccharides-CRM197 glycoconjugates","volume":"27","author":"Kabanova","year":"2010","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0175","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1016\/S0142-9612(03)00351-X","article-title":"Biomimetic design in microparticulate vaccines","volume":"24","author":"Keegan","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0180","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1021\/mp700089s","article-title":"Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells","volume":"5","author":"Kitchens","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijpharm.2009.10.017","article-title":"Drug release characteristics of PAMAM dendrimer-drug conjugates with different linkers","volume":"384","author":"Kurtoglu","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0190","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1021\/bc034095g","article-title":"Polyplexes assembled with internally quaternized PAMAM-OH dendrimer and plasmid DNA have a neutral surface and gene delivery potency","volume":"14","author":"Lee","year":"2003","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0195","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1099\/jmm.0.05093-0","article-title":"Chlamydial vaccine development","volume":"52","author":"Longbottom","year":"2003","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0200","first-page":"383","article-title":"Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice","volume":"38","author":"Lyons","year":"2005","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.drudis.2010.01.009","article-title":"Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications","volume":"15","author":"Menjoge","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0210","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.nano.2011.04.008","article-title":"PAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections","volume":"7","author":"Mishra","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0215","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1002\/adma.201200446","article-title":"Engineering nano- and microparticles to tune immunity","volume":"24","author":"Moon","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.taap.2010.04.014","article-title":"Reactive oxygen species (ROS) induced cytokine production and cytotoxicity of PAMAM dendrimers in J774A.1 cells","volume":"246","author":"Naha","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0225","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-3659(99)00097-8","article-title":"Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins","volume":"61","author":"Nakanishi","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0230","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1586\/erv.10.89","article-title":"Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses","volume":"9","author":"Oyewumi","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0235","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.4161\/hv.29418","article-title":"Peptide-based vaccines for cancer therapy","volume":"10","author":"Parmiani","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0240","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1517\/17425247.5.8.825","article-title":"Evolution of phage display: from bioactive peptides to bioselective nanomaterials","volume":"5","author":"Petrenko","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0245","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0264-410X(98)00256-4","article-title":"Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses","volume":"17","author":"Rajananthanan","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0250","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1128\/IAI.67.6.3019-3025.1999","article-title":"Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection","volume":"67","author":"Ramsey","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0255","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/535683","article-title":"High-resolution imaging of polyethylene glycol coated dendrimers via combined atomic force and scanning tunneling microscopy","author":"Riechers","year":"2015","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q","article-title":"Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst\u2122 dendrimers","volume":"30","author":"Roberts","year":"1996","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0265","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.addr.2011.09.010","article-title":"Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery","volume":"64","author":"Sadekar","year":"2012","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0270","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s11095-014-1419-y","article-title":"Biomaterials for nanoparticle vaccine delivery systems","volume":"33","author":"Sahdev","year":"2014","journal-title":"Phar. Res."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0275","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/RMHP.S12710","article-title":"Public health policies and management strategies for genital Chlamydia trachomatis infection","volume":"4","author":"Shaw","year":"2011","journal-title":"Risk. Manag. Healthc. Policy"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0280","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/eji.200737578","article-title":"Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo","volume":"38","author":"Sheng","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0285","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1586\/14760584.6.5.797","article-title":"Nanoparticles and microparticles as vaccine-delivery systems","volume":"6","author":"Singh","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0290","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1021\/cr960065d","article-title":"Phage display","volume":"97","author":"Smith","year":"1997","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0295","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.micinf.2003.09.004","article-title":"Association of Chlamydia pneumoniae with central nervous system disease","volume":"5","author":"Stratton","year":"2003","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0300","first-page":"469","article-title":"Some characteristics of a secreted chlamydial antigen recognized by IgG from C. trachomatis patient sera","volume":"68","author":"Stuart","year":"1989","journal-title":"Immunology"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0305","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.addr.2005.09.018","article-title":"Dendrimers in biomedical applications\u2013reflections on the field","volume":"57","author":"Svenson","year":"2005","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0310","first-page":"1199","article-title":"Clearance of chlamydial elementary bodies from the conjunctival sac","volume":"28","author":"Taylor","year":"1987","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0315","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/molecules21070867","article-title":"Advanced nanobiomaterials: vaccines, diagnosis and treatment of infectious diseases","volume":"21","author":"Torres-Sangiao","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0320","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1126\/science.288.5465.522","article-title":"Transport of peptide-MHC class II complexes in developing dendritic cells","volume":"288","author":"Turley","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0325","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1016\/j.vaccine.2010.02.064","article-title":"Vaccination of turkeys against Chlamydophila psittaci through optimised DNA formulation and administration","volume":"28","author":"Verminnen","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0330","doi-asserted-by":"crossref","first-page":"0217","DOI":"10.1007\/s00284-002-3843-1","article-title":"A role for the glycolipid exoantigen (GLXA) in chlamydial infectivity","volume":"46","author":"Vora","year":"2003","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0335","doi-asserted-by":"crossref","first-page":"e0146934","DOI":"10.1371\/journal.pone.0146934","article-title":"A prototype recombinant-protein based Chlamydia pecorum vaccine results in reduced chlamydial burden and less clinical disease in free-ranging koalas (Phascolarctos cinereus)","volume":"11","author":"Waugh","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0340","unstructured":"Whittum-Hudson, J., Hudson, A.P., 2011. Genus-wide chlamydial peptide vaccine antigens. US Patent No. 20110236484."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0345","first-page":"1976","article-title":"Murine model of ocular infection by a human biovar of Chlamydia trachomatis","volume":"36","author":"Whittum-Hudson","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0350","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nm1096-1116","article-title":"Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection","volume":"2","author":"Whittum-Hudson","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0355","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1016\/S0264-410X(01)00117-7","article-title":"The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis","volume":"19","author":"Whittum-Hudson","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0360","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.biomaterials.2004.07.050","article-title":"Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs","volume":"26","author":"Win","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0365","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/jcp.52.5.398b","article-title":"Chlamydia pneumoniae and atherosclerosis","volume":"52","author":"Wong","year":"1999","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0370","unstructured":"Wright D.C., 1998, Adjuvant properties of poly (amidoamine) dendrimers. U.S. Patent No. 5,795,582."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0375","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1021\/mp400630z","article-title":"PEGylated, NH2-terminated PAMAM dendrimers: a microscopic view from atomistic computer simulations","volume":"11","author":"Yang","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0380","doi-asserted-by":"crossref","DOI":"10.1586\/14760584.2016.1161510","article-title":"Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis","author":"Yu","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0385","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0390","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/acs.molpharmaceut.5b00876","article-title":"Poly (amidoamine) dendrimer-doxorubicin conjugates: in vitro characteristics and pseudo-solution formulation in pressurized metered-dose inhalers","volume":"13","author":"Zhong","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0395","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1021\/acs.molpharmaceut.6b00126","article-title":"Conjugation to poly(amidoamine) dendrimers and pulmonary delivery reduce cardiac accumulation and enhance antitumor activity of doxorubicin in lung metastasis","volume":"13","author":"Zhong","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2017.05.045_bib0400","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1021\/acs.molpharmaceut.6b00036","article-title":"Effect of the route of administration and PEGylation of poly (amidoamine) dendrimers on their systemic and lung cellular biodistribution","volume":"13","author":"Zhong","year":"2016","journal-title":"Mol. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731730457X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731730457X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T06:54:56Z","timestamp":1602140096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037851731730457X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":80,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S037851731730457X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.05.045","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendrimer-conjugated peptide vaccine enhances clearance of Chlamydia trachomatis genital infection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.05.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}